TickerFacts.

RxSight, Inc. (RXST): Total Liabilities

Annual figures by period end, from SEC filings.

$36.13M
As of 2025-12-31
$89.36M
As of 2026-06-30
-15.7%
3-year compound annual growth
-4.3%
5-year compound annual growth
$60.26M2020-12-31: $44.91M2021-12-31: $54.48M2022-12-31: $60.26M2023-12-31: $22.19M2024-12-31: $37.33M2025-12-31: $36.13M$36.13M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$36.13M-3.2%2026-02-25, Balance as of period end
2024-12-31$37.33M+68.2%2026-02-25, Balance as of period end
2023-12-31$22.19M-63.2%2025-02-25, Balance as of period end
2022-12-31$60.26M+10.6%2024-02-28, Balance as of period end
2021-12-31$54.48M+21.3%2023-03-06, Balance as of period end
2020-12-31$44.91Mn/a2022-03-08, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
RxSight, Inc. (RXST)2025-12-31$36.13M-3.2%
Staar Surgical Co (STAA)2026-01-02$107.49M-4.2%
Warby Parker Inc. (WRBY)2025-12-31$353.19M+5.0%
Cooper Companies, Inc. (COO)2025-10-31$4.16B-1.8%
Bausch & Lomb Corp (BLCO)2025-12-31$7.50B+8.3%
Innovative Eyewear Inc (LUCY)2025-12-31$1.07M+44.5%

Compare RXST, STAA, WRBY, COO side by side · Screen every company in Ophthalmic Goods ↗